BIOA (STOCKS)
BioAge Labs, Inc. Common Stock
$19.990000
-0.200000 (-0.99%)
Prev close: $20.190000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Kristen Fortney
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $834.21M
- Employees
- 64
- P/E (TTM)
- -9.55
- P/B (TTM)
- 2.61
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $5.92M |
| Nonoperating Income/Loss | $13.93M |
| Operating Expenses | $95.64M |
| Research and Development | $68.69M |
| Other Operating Expenses | $26.95M |
| Operating Income/Loss | -$89.72M |
| Income/Loss From Continuing Operations After Tax | -$75.79M |
| Income/Loss From Continuing Operations Before Tax | -$53.57M |
| Net Income/Loss | -$75.79M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$75.79M |
| Net Income/Loss Available To Common Stockholders, Basic | -$75.79M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $13.61 |
| Diluted Earnings Per Share | $13.61 |
| Basic Average Shares | 80,129,198 |
| Diluted Average Shares | 80,129,198 |
| Assets | $305.09M |
| Current Assets | $290.83M |
| Noncurrent Assets | $14.26M |
| Fixed Assets | $973.00K |
| Other Non-current Assets | $13.29M |
| Liabilities | $27.63M |
| Current Liabilities | $24.49M |
| Accounts Payable | $5.02M |
| Wages | $3.16M |
| Other Current Liabilities | $16.32M |
| Noncurrent Liabilities | $3.13M |
| Equity | $277.46M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $277.46M |
| Liabilities And Equity | $305.09M |
| Net Cash Flow From Operating Activities | -$58.51M |
| Net Cash Flow From Operating Activities, Continuing | -$58.51M |
| Net Cash Flow From Investing Activities | -$80.81M |
| Net Cash Flow From Investing Activities, Continuing | -$80.81M |
| Net Cash Flow From Financing Activities | $20.36M |
| Net Cash Flow From Financing Activities, Continuing | $20.36M |
| Net Cash Flow | -$118.97M |
| Net Cash Flow, Continuing | -$118.97M |
| Comprehensive Income/Loss | -$75.74M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$75.74M |
| Other Comprehensive Income/Loss | -$20.12M |